Insider · CIK 0001745938
Jennifer L Taubert
Files at MCD (MCDONALDS CORP), JNJ (JOHNSON & JOHNSON). First filing Sep 5, 2025, latest Aug 18, 2026.
In brief
Jennifer L Taubert files SEC Form 4 as officer and director at JNJ (JOHNSON & JOHNSON), and also at MCD (MCDONALDS CORP). Since Sep 5, 2025, Jennifer L Taubert has reported 0 open-market buys worth $0 and 2 open-market sells worth $14M, the latest filed on Aug 18, 2026.
A track record needs three past buys with six months of prices behind them; Jennifer L Taubert has 0, so none is measured yet.
The newest scored trade: sold $4.0M of JNJ on Aug 17, 2026, filed Aug 18, 2026, scored 40 (moderate). In the last 12 months: 0 buys worth $0 and 1 sell worth $4.0M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
JNJ: JOHNSON & JOHNSON
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | JOHNSON & JOHNSON | $4.0M 15,000 shares | -7% | +53% from low-2% from high | |
| 38Weak | JOHNSON & JOHNSON | $10M 56,471 shares | -24% | +29% from low0% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 17, 2026 | JNJ JOHNSON & JOHNSON | 15,000 0.00% of outstanding | $4.0M | Aug 17, 2026 | none |
| Sep 4, 2025 | JNJ JOHNSON & JOHNSON | 56,471 0.00% of outstanding | $10M | Sep 4, 2025 | none |
| Feb 9, 2024 | JNJ JOHNSON & JOHNSON | 59,397 0.00% of outstanding | $9.3M | Feb 9, 2024 | none |
Transactions
Every row this insider has filed, 46 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | MCD MCDONALDS CORP | AGrant or award Phantom Stockderivative | +130 | $230.94 | $30k | 4,109 | 11 d ago |
| Aug 17, 2026 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +15,000 | $115.67 | $1.7M | 209,451 | Aug 18, 2026 |
| Aug 17, 2026 | JNJ JOHNSON & JOHNSON | SOpen-market sale Common Stock | -15,000 | $263.36 | $4.0M | 194,451 | Aug 18, 2026 |
| Aug 17, 2026 | JNJ JOHNSON & JOHNSON | MOption exercise Employee Stock Options (Right to Buy)derivative | -15,000 | $0.00 | $0 | 28,712 | Aug 18, 2026 |
| Mar 31, 2026 | MCD MCDONALDS CORP | AGrant or award Phantom Stockderivative | +97 | $310.79 | $30k | 3,814 | Jul 2, 2026 |
| Jun 30, 2026 | MCD MCDONALDS CORP | AGrant or award Phantom Stockderivative | +111 | $270.31 | $30k | 3,949 | Jul 2, 2026 |
| Feb 13, 2026 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +1,302 | $0.00 | $0 | 179,315 | Feb 18, 2026 |
| Feb 13, 2026 | JNJ JOHNSON & JOHNSON | FTax withholding Common Stock | -409 | $244.55 | $100k | 178,906 | Feb 18, 2026 |
| Feb 13, 2026 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +27,412 | $0.00 | $0 | 206,318 | Feb 18, 2026 |
| Feb 13, 2026 | JNJ JOHNSON & JOHNSON | FTax withholding Common Stock | -13,547 | $244.55 | $3.3M | 192,771 | Feb 18, 2026 |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +1,594 | $0.00 | $0 | 194,365 | Feb 18, 2026 |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | FTax withholding Common Stock | -816 | $243.45 | $199k | 193,549 | Feb 18, 2026 |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +1,847 | $0.00 | $0 | 195,396 | Feb 18, 2026 |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | FTax withholding Common Stock | -945 | $243.45 | $230k | 194,451 | Feb 18, 2026 |
| Feb 13, 2026 | JNJ JOHNSON & JOHNSON | MOption exercise Restricted Share Unitsderivative | -1,302 | $0.00 | $0 | 0 | Feb 18, 2026 |
| Feb 13, 2026 | JNJ JOHNSON & JOHNSON | MOption exercise Performance Share Unitsderivative | -27,412 | $0.00 | $0 | 0 | Feb 18, 2026 |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | MOption exercise Restricted Share Unitsderivative | -1,594 | $0.00 | $0 | 1,594 | Feb 18, 2026 |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | MOption exercise Restricted Share Unitsderivative | -1,847 | $0.00 | $0 | 3,692 | Feb 18, 2026 |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | AGrant or award Employee Stock Options (Right to Buy)derivative | +54,869 | $0.00 | $0 | 54,869 | Feb 18, 2026 |
| Feb 15, 2026 | JNJ JOHNSON & JOHNSON | AGrant or award Restricted Share Unitsderivative | +3,940 | $0.00 | $0 | 3,940 | Feb 18, 2026 |
| Feb 9, 2026 | JNJ JOHNSON & JOHNSON | AGrant or award Performance Share Unitsderivative | +27,412 | $0.00 | $0 | 27,412 | Feb 11, 2026 |
| Dec 31, 2025 | MCD MCDONALDS CORP | AGrant or award Phantom Stockderivative | +769 | $305.63 | $235k | 3,696 | Jan 5, 2026 |
| Sep 30, 2025 | MCD MCDONALDS CORP | AGrant or award Phantom Stockderivative | +99 | $303.89 | $30k | 2,910 | Oct 1, 2025 |
| Sep 4, 2025 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +56,471 | $101.87 | $5.8M | 234,484 | Sep 5, 2025 |
| Sep 4, 2025 | JNJ JOHNSON & JOHNSON | SOpen-market sale Common Stock | -56,471 | $177.81 | $10M | 178,013 | Sep 5, 2025 |
| Sep 4, 2025 | JNJ JOHNSON & JOHNSON | MOption exercise Employee Stock Options (Right to Buy)derivative | -56,471 | $101.87 | $5.8M | 0 | Sep 5, 2025 |
| Jun 30, 2025 | MCD MCDONALDS CORP | AGrant or award Phantom Stockderivative | +103 | $292.17 | $30k | 2,692 | Jul 1, 2025 |
| Mar 31, 2025 | MCD MCDONALDS CORP | AGrant or award Phantom Stockderivative | +96 | $312.37 | $30k | 2,676 | Apr 2, 2025 |
| Feb 15, 2025 | JNJ JOHNSON & JOHNSON | AGrant or award Employee Stock Options (Right to Buy)derivative | +89,781 | $0.00 | $0 | 89,781 | Feb 19, 2025 |
| Feb 15, 2025 | JNJ JOHNSON & JOHNSON | AGrant or award Restricted Share Unitsderivative | +5,539 | $0.00 | $0 | 5,539 | Feb 19, 2025 |
| Feb 13, 2025 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +1,302 | $0.00 | $0 | 167,221 | Feb 18, 2025 |
| Feb 14, 2025 | JNJ JOHNSON & JOHNSON | FTax withholding Common Stock | -410 | $155.26 | $64k | 166,811 | Feb 18, 2025 |
| Feb 14, 2025 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +4,053 | $0.00 | $0 | 170,864 | Feb 18, 2025 |
| Feb 14, 2025 | JNJ JOHNSON & JOHNSON | FTax withholding Common Stock | -1,348 | $156.71 | $211k | 169,516 | Feb 18, 2025 |
| Feb 15, 2025 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +1,594 | $0.00 | $0 | 171,110 | Feb 18, 2025 |
| Feb 18, 2025 | JNJ JOHNSON & JOHNSON | FTax withholding Common Stock | -651 | $156.15 | $102k | 170,459 | Feb 18, 2025 |
| Feb 14, 2025 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +15,465 | $0.00 | $0 | 185,924 | Feb 18, 2025 |
| Feb 14, 2025 | JNJ JOHNSON & JOHNSON | FTax withholding Common Stock | -7,911 | $156.71 | $1.2M | 178,013 | Feb 18, 2025 |
| Feb 13, 2025 | JNJ JOHNSON & JOHNSON | MOption exercise Restricted Share Unitsderivative | -1,302 | $0.00 | $0 | 1,302 | Feb 18, 2025 |
| Feb 14, 2025 | JNJ JOHNSON & JOHNSON | MOption exercise Restricted Share Unitsderivative | -4,053 | $0.00 | $0 | 0 | Feb 18, 2025 |
| Feb 15, 2025 | JNJ JOHNSON & JOHNSON | MOption exercise Restricted Share Unitsderivative | -1,594 | $0.00 | $0 | 3,188 | Feb 18, 2025 |
| Feb 14, 2025 | JNJ JOHNSON & JOHNSON | MOption exercise Performance Share Unitsderivative | -15,465 | $0.00 | $0 | 0 | Feb 18, 2025 |
| Feb 10, 2025 | JNJ JOHNSON & JOHNSON | AGrant or award Performance Share Unitsderivative | +15,465 | $0.00 | $0 | 15,465 | Feb 12, 2025 |
| Feb 7, 2025 | JNJ JOHNSON & JOHNSON | MOption exercise Common Stock | +58,504 | $100.06 | $5.9M | 213,355 | Feb 11, 2025 |
| Feb 7, 2025 | JNJ JOHNSON & JOHNSON | FTax withholding Common Stock | -47,436 | $153.12 | $7.3M | 165,919 | Feb 11, 2025 |
| Feb 7, 2025 | JNJ JOHNSON & JOHNSON | MOption exercise Employee Stock Options (Right to Buy)derivative | -58,504 | $100.06 | $5.9M | 0 | Feb 11, 2025 |
Questions about Jennifer L Taubert
Answered from the filings on this page, as of the latest one.
Is Jennifer L Taubert buying or selling?
In the last 12 months Jennifer L Taubert reported 0 open-market buys worth $0 and 1 open-market sell worth $4.0M on SEC Form 4; the latest was sold $4.0M of JNJ on Aug 17, 2026. Grants, option exercises and tax withholding are not counted.
How did Jennifer L Taubert's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jennifer L Taubert has 0.
Where does Jennifer L Taubert file Form 4?
Jennifer L Taubert has filed Form 4 at JNJ (JOHNSON & JOHNSON) as EVP, WWC. Innovative Medicine; MCD (MCDONALDS CORP). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.